Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;24(6):315-323.
doi: 10.2217/pgs-2023-0032. Epub 2023 Apr 26.

Patient satisfaction with return of pharmacogenomic results utilizing a patient portal message

Joel Van Heukelom  1   2 , Kristen Jacobsen  1 , Natasha J Petry  1   3 , April Schultz  1   2 , Jordan Baye  1   2   4 , David Sturdevant  5 , Amanda Massmann  1   2
Affiliations

Patient satisfaction with return of pharmacogenomic results utilizing a patient portal message

Joel Van Heukelom et al. Pharmacogenomics. 2023 Apr.

Abstract

Background: Returning pharmacogenomics (PGx) results to patients is complex and challenging. Patients prefer provider education; however, a gap in provider comfort in PGx results has been documented. Objectives: This study's purpose was to evaluate satisfaction with the return of PGx test results using a patient portal message. Methods: A survey was sent to two cohorts with PGx results, one that received a PGx result message and one that did not. Results: Following implementation of the PGx result message, there was a decrease in patients reporting negative responses surrounding satisfaction in the return of their PGx results, with 39% responding negatively pre-implementation and 21% post-implementation. Conclusion: Satisfaction with the return of results improved following the implementation of a patient portal message.

Keywords: humans; patient satisfaction; personal satisfaction; pharmacists; pharmacogenetics; surveys and questionnaires.

PubMed Disclaimer

Conflict of interest statement

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Figures

Figure 1.
Figure 1.. Pharmacogenomics team patient communication workflow with the initial implementation of the patient result message.
(A) Prior to this analysis and (B) post-analysis. Post-analysis included sending the patient result message to all patients with panel-based testing. PGx: Pharmacogenomics; PRM: Pharmacogenomics result message.
Figure 2.
Figure 2.. Methodology of sending patients surveys utilized by the study team.
PRM: Pharmacogenomics result message.
Figure 3.
Figure 3.. Results to the question, “How satisfied are you with how your pharmacogenomics results were returned to you?”.
PRM: Pharmacogenomics result message.
Figure 4.
Figure 4.. Results to the question, “How satisfied are you with the explanation you received about your pharmacogenomics results?”.
PRM: Pharmacogenomics result message.
See this image and copyright information in PMC

References

    1. National Institute of General Medical Sciences. Pharmacogenomics. https://nigms.nih.gov/education/fact-sheets/Pages/pharmacogenomics.aspx
    1. Olson JE, Rohrer Vitek CR, Bell EJ et al. Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time). Genet. Med. 19(7), 819–825 (2017). - PMC - PubMed
    1. Lautenbach DM, Christensen KD, Sparks JA, Green RC. Communicating genetic risk information for common disorders in the era of genomic medicine. Annu. Rev. Genom. Hum. Genet. 14(1), 491–513 (2013). - PMC - PubMed
    1. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers: development of the patient activation measure (PAM). Health Serv. Res. 39(4 pt 1), 1005–1026 (2004). - PMC - PubMed
    1. Jones LK, Kulchak Rahm A, Gionfriddo MR et al. Developing pharmacogenomic reports: insights from patients and clinicians. Clin. Transl. Sci. 11(3), 289–295 (2018). - PMC - PubMed

Publication types

LinkOut - more resources